agilon health, inc. (AGL)
NYSE: AGL · IEX Real-Time Price · USD
5.33
-0.01 (-0.19%)
Apr 24, 2024, 4:00 PM EDT - Market closed

agilon health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
4,3162,3881,5211,218794.41474.83
Revenue Growth (YoY)
80.74%56.97%24.88%53.36%67.31%-
Cost of Revenue
4,2472,2771,4561,124765.9446.76
Gross Profit
69.67111.3665.7494.1528.5128.07
Selling, General & Admin
285.76207.79427.5137.29122.8388.75
Other Operating Expenses
16.048.9510.4813.5312.2511.39
Operating Expenses
301.8216.74437.99150.82135.09100.13
Operating Income
-232.13-105.38-372.24-56.67-106.57-72.06
Interest Expense / Income
6.664.486.158.149.079.84
Other Expense / Income
23.01-4.9527.21-5.62167.1865.14
Pretax Income
-261.81-104.91-405.6-59.19-282.82-147.04
Income Tax
0.791.640.890.87-0.23-0.11
Net Income
-262.6-106.55-406.49-60.05-282.59-146.93
Shares Outstanding (Basic)
409408373323295251
Shares Outstanding (Diluted)
409408373323295251
Shares Change
0.19%9.44%15.29%9.75%17.53%-
EPS (Basic)
-0.64-0.26-1.09-0.19-0.96-0.59
EPS (Diluted)
-0.64-0.26-1.09-0.19-0.96-0.59
Free Cash Flow
-172.03-146.23-154.72-54.98-106.75-69.63
Free Cash Flow Per Share
-0.42-0.36-0.41-0.17-0.36-0.28
Gross Margin
1.61%4.66%4.32%7.73%3.59%5.91%
Operating Margin
-5.38%-4.41%-24.47%-4.65%-13.42%-15.18%
Profit Margin
-6.08%-4.46%-26.72%-4.93%-35.57%-30.94%
Free Cash Flow Margin
-3.99%-6.12%-10.17%-4.51%-13.44%-14.66%
EBITDA
-234.99-86.66-384.79-36.95-232.34-116.02
EBITDA Margin
-5.44%-3.63%-25.29%-3.03%-29.25%-24.43%
Depreciation & Amortization
20.1613.7714.6714.141.4121.18
EBIT
-255.15-100.43-399.46-51.05-273.75-137.2
EBIT Margin
-5.91%-4.21%-26.25%-4.19%-34.46%-28.89%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).